Herantis Pharma Phase 1 study results of Cis-UCA Eye Drops

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jan 26, 2015 at 3:15 AM

Herantis Pharma Phase 1 study results of Cis-UCA Eye Drops published

Herantis Pharma Phase 1 study results of Cis-UCA Eye Drops published Herantis Pharma Plc. Company release 26 January 2015 at 10:00 am Results of the Phase 1 clinical study of Cis-UCA Eye Drops of Herantis Pharma have been published in the scientific journal Acta Ophthalmologica. The peer- reviewed article concludes that topical ocular administration of cis-UCA Eye Drops three times a day for 14 days is safe and well tolerated in healthy adults. "It is always rewarding to have a drug candidate's safety - one of its essential attributes - confirmed through publishing in an international peer-reviewed journal", says Burkhard Blank, MD, Herantis' Chief Medical Officer. "It is exceptionally exciting that it coincides with the recent initiation of our consecutive Phase 2 efficacy study." "We really value the expertise and high quality of research conducted at the University of Eastern Finland", adds Henri Huttunen, PhD, Herantis' Chief Scientific Officer. "The entire Cis-UCA development program is a great example of what can be achieved through a good university-industry collaboration - a cornerstone of Herantis." The published article titled "A randomized phase I clinical study of cis- urocanic acid eye drops in healthy adult subjects" will appear in Acta Ophthalmologica and is now available online ahead of printing under the identifier: doi: 10.1111/aos.12651. Further information: Herantis Pharma plc., Pekka Simula, CEO, telephone: +358 40 7300 445 Company web site: www.herantis.com Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225 About Dry Eye Syndrome Dry Eye Syndrome (Keratoconjunctivitis sicca) is the most common cause of irritation in the eye. Typical subjective symptoms include dryness, burning sensation, pain, redness, and feeling of dirt in the eye. A severe or prolonged Dry Eye Syndrome may lead to complications causing damage to the surface of the eye and impaired vision. Dry Eye Syndrome is expected to become more prevalent with the aging population and with increasing use of computers and mobile devices. About Cis-UCA Eye Drops Cis-UCA Eye Drops is an ophthalmic solution indicated for the treatment of the signs and symptoms of Dry Eye Syndrome. Cis-urocanic acid (Cis-UCA), the active product ingredient of Cis-UCA Eye Drops, is an endogenous small molecule component of human and animal skin. It is constantly present in the human body and has been identified as a locally acting anti-inflammatory agent, which also reduces free radicals. Cis-UCA Eye Drops has previously been investigated in an experimental model of dry eye in the mouse, to simulate the Phase 2 clinical study. The results indicate that 1% Cis-UCA Eye Drops is efficacious in reducing corneal fluorescein staining in the model and performs better than the clinical comparator, Restasis®. About drug development Drug development projects can usually be divided in two stages: The preclinical stage, and the clinical stage involving human subjects. The clinical stage can be further broken in three formal phases. Phase 1 clinical studies assess the safety of a drug candidate in human subjects. In Phase 2, the optimal dosing and possible efficacy in the treatment of a particular disease is studied. Phase 3 studies finally aim to establish a statistical proof of safety and efficacy of the drug candidate in typically hundreds or thousands of patients for market approval. Drug development can take 10-15 years from the first preclinical studies to market approval. About Herantis Pharma Plc. Herantis Pharma Plc. is a pharmaceutical company specialised in new drug research and development. The company focuses on diseases with an unmet clinical need. These diseases include for example dry eye syndrome, Parkinson's disease, and secondary lymphedema. We believe our drugs are the first or best in their class and have the potential to change treatment strategies of diseases. The shares of Herantis Pharma Plc. are listed on the First North Finland marketplace run by NASDAQ Helsinki stock exchange. [HUG#1889171]

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chicken Salad Chick's Utah Expansion: The Next Course

A New Serving in Spanish Fork Chicken Salad Chick is taking another bite out of the Utah market with the opening of its second location in Spanish Fork. On deck for a November 17 debut, this fast-casual chain is serving up not just chicken salad, but a hefty dose of Southern hospitality and promotional giveaways to boot. The big hook? Be among the first 100 patrons and...

Reju Partners with Six Mills to Advance Textile Regeneration

Big Moves in Textile Regeneration Now here's a move that's got the fabric world buzzing: Reju, the scrappy textile-to-textile regenerative powerhouse, is teaming up with six mills spread across Europe and the U.S. They’re setting the stage to crank up their polyester recycling game and flood the market with sustainable, eco-friendly fabrics. It's a bold step toward...

Surgical Planning Associates Expands HipInsight Options

A Broader Horizon for Hip Surgery Planning Well, here we go—a medical technology play that's actually stirring things up, and not just blowing smoke. Surgical Planning Associates (SPA)—a name you might wanna keep an eye on—is turning heads with their HipInsight System. Just this week, they let it be known they've added five more implant systems to their 3D...

Ultima Genomics Drives Precision Medicine Forward in Singapore

A Major Milestone for Precision Medicine Ultima Genomics just nabbed a big one, folks. They're going front and center with Singapore's National Precision Medicine (NPM) Program for Phase III, marking no small feat in the ambitious world of genomics. This is more than just another feather in their cap—it's a power move in the cutthroat race for sequencing supremacy. And...

Memoir 'Pinball' Explores Life's Unpredictable Momentum

Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...

Academy Sports Teams Up With Little Debbie for Holidays

Collaboration Brews Between Academy and Little Debbie Holiday cheer isn't complete without a mash-up that gets tongues wagging and wallets opening. Only this time, a sporting goods giant and your favorite snack cake brand are bringing us the yuletide spirit. Academy Sports + Outdoors has teamed up with Little Debbie for a limited-time collaboration under its Magellan...

Timing Key for Cost-Effective Car Shipping: Jackie Ramirez

The Wisdom of Early Car Shipping Planning If there's one thing I've learned through years of trading ticks and ticks of the clock in the market, it's that timing can make or break you. Well, seems like those same lessons carry over to the world of getting your ride from A to B. The skinny from HelloNation's latest piece featuring vehicle transport guru Jackie Ramirez is...

First FedRAMP® 20x Class C Certification Earned

Shifting Landscapes in Cybersecurity Certifications Change is the only constant in tech, and 360 Advanced sure knows how to ride that wave by leaping into the murky waters of FedRAMP's newest class. They’ve stamped their name on this historic FedRAMP® 20x Class C Certification by playing the role of the independent assessor for Perplexity's cloud service—a first...

Machias Power Urges Generator Prep for WA Winter Storms

Winter Woes: Homeowners Need to Think Ahead It's that time again, folks. The drizzle in Washington is turning into something fiercer, and Machias Power and Plumbing isn't beating around the bush—they're telling us to stop dragging our feet on getting standby generators. After last year's blow where storms hit us with flooding and outages, you’d think we’d have...

Watches of Switzerland Dazzles with Holiday Campaign

Swiss Timepieces Take Center Stage Ever feel like there's a certain art to gift-giving? Apparently, The Watches of Switzerland Group thinks so, and they're not holding back in showing us how it's done with their new 'Brilliantly Given' campaign. They’re taking a classic approach by spotlighting luxury timepieces and fine jewelry just in time for the holiday...